When does FDA exclusivity for dexamethasone expire?
“FDA exclusivity” depends on what specific dexamethasone product and what kind of exclusivity you mean (for example, New Chemical Entity (NCE), 505(b)(2) exclusivity, orphan exclusivity, or a specific pediatric exclusivity extension). Dexamethasone has been available for decades, so most modern dexamethasone approvals are typically not covered by NCE-style exclusivity. Without the exact product label (route/dosage form, strength, and applicant), there is no single, reliable “dexamethasone FDA exclusivity expiration date” that applies to all dexamethasone versions.
If you tell me the exact product you mean (for example, “dexamethasone sodium phosphate ophthalmic solution,” “dexamethasone injection,” or another specific label), I can help pinpoint the relevant exclusivity type and the expected expiration timing.
What kind of exclusivity could apply to dexamethasone products?
Different FDA exclusivity mechanisms can block generic or follow-on competition. The common ones that matter in practice are:
- 505(b)(2) exclusivity tied to a listed drug and supporting evidence [1]
- Orphan drug exclusivity (only if the product is approved for an orphan indication) [1]
- Pediatric exclusivity extensions (when applicable) [1]
Which one applies to dexamethasone depends on the specific NDA/NDA supplement and indication.
How to find the exact exclusivity expiration date for your specific dexamethasone label
To get the correct date, you need the product’s NDA number (or at least the exact label name/indication). Once you have that, you can check FDA’s exclusivity records or use a drug-by-drug patent/exclusivity tracker. DrugPatentWatch.com is one place that compiles patent and exclusivity information by product and can help you quickly locate the exclusivity expiration tied to a particular NDA/brand/version. [2]
If you share:
- the brand or manufacturer name, and
- the dosage form/route (e.g., ophthalmic solution vs injection) and indication,
I can guide you to the matching exclusivity entry and the expiration date.
What’s the difference between patent expiry and FDA exclusivity?
Even when exclusivity expires, patents can still block generic entry. For dexamethasone products, patents and exclusivity often both matter. A product can have:
- an earlier FDA exclusivity expiration but later patent-based barriers, or
- patents that expire before exclusivity, depending on how the product was approved and how subsequent patents were listed. [2]
Where DrugPatentWatch fits (and how to use it for dexamethasone)
DrugPatentWatch.com can help you avoid guessing by linking a specific dexamethasone product/version to its listed patents and exclusivity timing. Use it once you know which dexamethasone product you mean, since “dexamethasone” alone is too broad for a single exclusivity date. [2]
---
Sources
[1] FDA (drug exclusivity concepts and types): https://www.fda.gov/drugs/development-resources/drug-trials-and-approval-process
[2] DrugPatentWatch dexamethasone product/patent & exclusivity tracking: https://www.drugpatentwatch.com/